Coverage of Health Care Sector Stocks -- Research on Agilent Technologies, Thermo Fisher Scientific, Nordion, and BG Medicine

LONDON, April 15, 2014 /PRNewswire/ --

On Monday, April 14, 2014, the NASDAQ Composite ended at 4,022.69, up 0.57%, the Dow Jones Industrial Average advanced 0.91% to 16,173.24, and the S&P 500 closed at 1,830.61, up 0.82%. The gains were broad based as all the 10 sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 648.05, up 0.51%, while the same has declined 3.97% in the last one month. Investor-Edge has initiated coverage on the following equities: Agilent Technologies Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE: TMO), Nordion Inc. (NYSE: NDZ) and BG Medicine Inc. (NASDAQ: BGMD). Free technical research on A, TMO, NDZ and BGMD can be downloaded upon signing up at:

http://www.investor-edge.com/1240-register

Agilent Technologies Inc.'s stock declined 0.23% on Monday, closing at $52.65, after oscillating between $52.31 and $53.25. A total of 2.84 million shares were traded, which is below its three months average volume of 2.87 million shares. Shares in Agilent Technologies Inc. have lost 5.03% in the last one month and 7.94% on YTD basis. The company's stock is trading above its 200-day moving average. Agilent Technologies Inc.'s 50-day moving average of $56.65 is above its 200-day moving average of $52.56. Furthermore, the company's stock is trading at a PE ratio of 20.89 and has a Relative Strength Index (RSI) of 34.08. Sign up today to read free research on A at:

http://www.investor-edge.com/1240-A-15Apr2014.pdf

Shares in Thermo Fisher Scientific Inc. witnessed a trading volume of 1.52 million shares on Monday, as compared with its three months average volume of 2.63 million shares. The stock ended the day at $116.40, up 0.54%, after trading between $115.08 and $116.85. Thermo Fisher Scientific Inc.'s shares have declined 4.79% in the last one month, while the same has advanced 1.43% in the previous three months and 4.54% on YTD basis. The stock is trading above its 200-day moving average. Thermo Fisher Scientific Inc.'s 50-day moving average of $121.30 is above its 200-day moving average of $103.24. Additionally, the company's shares are trading at a PE ratio of 33.29 and have an RSI of 37.77. Sign up today to read free research on TMO at:

http://www.investor-edge.com/1240-TMO-15Apr2014.pdf

On Monday, Nordion Inc.'s shares gained 0.89% finishing the session at $11.37. The stock recorded a trading volume of 0.71 million shares which is below its three months average volume of 1.08 million shares. The stock fluctuated between $11.28 and $11.38 during the session. Shares in Nordion Inc. have rallied 9.96% in the last one month, 17.95% in the previous three months, and 33.92% on YTD basis. The stock is trading above its 50-day and 200-day moving averages. Nordion Inc.'s 50-day moving average of $10.24 is above its 200-day moving average of $8.75. Moreover, the company's shares have an RSI of 66.06. Sign up today to read free research on NDZ at:

http://www.investor-edge.com/1240-NDZ-15Apr2014.pdf

BG Medicine Inc. shares recorded a trading volume of 1.18 million shares, as compared with its three months average volume of 1.90 million shares. The stock ended Monday's session at $1.19, down 2.46%, and at an intraday trading range of $1.16 and $1.29. BG Medicine Inc.'s shares have gone down by 9.85% in the last one month and 13.77% in the previous three months, while the same has surged 14.42% on YTD basis. The stock is trading above its 200-day moving average. BG Medicine Inc.'s 50-day moving average of $1.44 is above its 200-day moving average of $1.07. Further, the company's shares have an RSI of 35.65. Sign up today to read free research on BGMD at:

http://www.investor-edge.com/1240-BGMD-15Apr2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://Investor-Edge.com

SOURCE Investor-Edge

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED